A 1,462% Bet on Tiny Bright Health Stock (BHG) Shows Option Math Is Hard

Discussion in 'Options' started by ETJ, Jul 13, 2023.

  1. BMK

    BMK

    Those numbers are not what you think they are. There was a reverse stock split, and it is very, very likely that the reason someone bought worthless call options that were way out of the money with almost no time left to expiration is because they did not understand that the option strike prices did not mean what they would normally mean because the option multiplier had to be adjusted after the reverse stock split.

    If you don't understand how a stock split affects options, they you are not going to understand the whole point of the article.
     
    #11     Jul 13, 2023
    athlonmank8 likes this.
  2. BMK

    BMK

    Why are you putting the word worthless in quotes?

    That implies that they were not actually worthless, when in fact they did expire worthless.
     
    #12     Jul 13, 2023
    athlonmank8 likes this.
  3. maxinger

    maxinger

    I assume the chart has factored in the stock split.

    Anyway, I wouldn't bother to check when / how much they split the stock.

    Assuming they have been splitting and splitting the stock all along,
    At the rate BHG is splitting the stock, soon it will be zero.
     
    #13     Jul 13, 2023
  4. You underestimate pure stupidity or a simple accident. Those options were junk. There was no market for them. If it was a mistake, what were they supposed to do??? Theres a zero bid dude
     
    #14     Jul 14, 2023
  5. M.W.

    M.W.

    Stupidity and 5 does not go together. Ever. There is more to the story than meets the eye. My bet is on an attempt of insider trading.

     
    #15     Jul 14, 2023
  6. newwurldmn

    newwurldmn

    They haven't expired yet.

    My guess is that an algo ran amuck. it kept trying to print and smarter algo's were happy to sell.

    This equates to 5% of the notional of the company - it would trigger disclosures the moment they tried to unwind the trade. If one had inside information there are more effective ways to trade this that wouldn't elicit the views of regulators.
     
    #16     Jul 14, 2023
  7. taowave

    taowave

    Read the article,and look before you leap

     
    #17     Jul 16, 2023
  8. ironchef

    ironchef

    It is too easy to blame insider trades.

    I trade options like venture investing (or running a corporate R&D department). Usually 4 out of 5 or even 9 out of 10 expire worthless. But all you need is an occasional 10x to be profitable.

    There are many clinical stage biotechs trading at deep discount and though 90% won't make it, a 10x payoff in options should easily compensate for the majority that will be worthless. Like venture investing, you just need the law of average and the law of large numbers.
     
    #18     Jul 17, 2023